Analysis | Follow-up Time | Risk difference per 1000 people | 95% CI | Numbers needed to harm | HR | 95% CI |
---|---|---|---|---|---|---|
As treated | 1 year | 0.9 | 0.4 to 1.4 | 1119 | 1.76 | 1.33 to 2.32 |
180-day lag, 180-day induction period | 2 year | 1.0 | 0.5 to 1.4 | 1052 | 1.73 | 1.33 to 2.24 |
5 year | 0.9 | 0.5 to 1.3 | 1107 | 1.67 | 1.30 to 2.14 | |
First treatment carried forward | 1 year | 0.5 | 0.2 to 0.9 | 1925 | 1.47 | 1.17 to 1.85 |
180-day induction period | 2 year | 0.5 | 0.2 to 0.8 | 1975 | 1.43 | 1.19 to 1.71 |
5 year | 0.5 | 0.2 to 0.7 | 2257 | 1.36 | 1.17 to 1.58 | |
As treated | 1 year | 0.4 | 0.0 to 0.8 | 2722 | 1.26 | 0.97 to 1.65 |
No lag or induction periods | 2 year | 0.5 | 0.1 to 0.9 | 1840 | 1.36 | 1.07 to 1.72 |
5 year | 0.6 | 0.2 to 0.9 | 1767 | 1.37 | 1.09 to 1.71 | |
First treatment carried forward, | 1 year | 0.3 | 0.0 to 0.6 | 3400 | 1.24 | 1.02 to 1.53 |
No induction period | 2 year | 0.4 | 0.1 to 0.6 | 2618 | 1.33 | 1.13 to 1.56 |
5 year | 0.4 | 0.2 to 0.6 | 2573 | 1.32 | 1.16 to 1.51 |
Numbers needed to harm rounded to integer.